Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma

The role of glypican-3 in the regulation of body size and cancer

(2011) Jorge Filmus et al.   CELL CYCLE

Cancer gene discovery in hepatocellular carcinoma

(2010) Lars Zender et al.   JOURNAL OF HEPATOLOGY

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

(2009) Hirofumi Shirakawa et al.   CANCER SCIENCE

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

(2008) Stefano Cairo et al.   CANCER CELL

Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by β-catenin/TCF

(2008) Yuichi Torisu et al.   CANCER SCIENCE

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway

(2008) Wei Cheng et al.   CARCINOGENESIS

Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding

(2008) Mariana I. Capurro et al.   DEVELOPMENTAL CELL

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

(2008) Jin-Ping Lai et al.   HEPATOLOGY

E2F1 Regulates the Base Excision Repair GeneXRCC1and Promotes DNA Repair

(2008) Dexi Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver

(2008) K. R. Reed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glypicans

(2008) Jorge Filmus et al.   GENOME BIOLOGY